RML Hospital's clinical study reports that Tofacitinib shows a remarkable 90% improvement in chronic hand eczema symptoms for ...

Hand eczema is a highly prevalent skin disease and one of the most common work-related disorders. In up to two-thirds of individuals affected by hand eczema, the disease becomes chronic and results in ...

Germany has become the debut market for LEO Pharma's Anzupgo, the first topical treatment specifically approved for chronic hand eczema (CHE). The launch of pan-JAK inhibitor Anzupgo (delgocitinib ...

Chronic hand eczema is multifactorial, with genetics and the environment contributing to its development. Credit: Andrzej Rostek via Shutterstock. Chronic hand eczema (CHE) is a persistent, ...

Chronic hand eczema (CHE) is a persistent, inflammatory skin disorder characterised by redness, itching, and the formation of vesicles on the hands that can result in pain and a significant ...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this ...

Danish dermatology specialist LEO Pharma could be just weeks away from EU approval for delgocitinib, a treatment for chronic hand eczema (CHE) considered to be its top pipeline prospect.